| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 辅酶Q10; Coenzyme Q10 | CFN99165 | 303-98-0 | C59H90O4 = 863.36 | 20mg | QQ客服：215959384 |
| 去氢-alpha-拉杷醌; Dehydro-alpha-lapachone | CFN99641 | 15297-92-4 | C15H12O3 = 240.3 | 5mg | QQ客服：1457312923 |
| 紫草素; Shikonin | CFN99907 | 517-88-4 | C16H16O5 = 288.31 | 20mg | QQ客服：215959384 |
| 异柿醌; Isodiospyrin | CFN98019 | 20175-84-2 | C22H14O6 = 374.4 | 5mg | QQ客服：1457312923 |
| 2,6-二甲氧基-1-乙酰甲基氢醌; 2,6-Dimethoxy-1-acetonylquinol | CFN98207 | 2215-96-5 | C11H14O5 = 226.2 | 5mg | QQ客服：1457312923 |
| 9-羟基-alpha-拉杷醌; 9-Hydroxy-alpha-lapachone | CFN98215 | 22333-58-0 | C15H14O4 = 258.3 | 5mg | QQ客服：2159513211 |
| 9-甲氧基-alpha-拉帕醌; 9-Methoxy-alpha-lapachone | CFN98463 | 35241-80-6 | C16H16O4 = 272.3 | 5mg | QQ客服：1457312923 |
| 去氧拉巴醌; Deoxylapachol | CFN98473 | 3568-90-9 | C15H14O2 = 226.3 | 5mg | QQ客服：1413575084 |
| 芦替菌素; Luteosporin | CFN98567 | 2530-39-4 | C28H18O12 = 546.44 | 5mg | QQ客服：3257982914 |
| alpha-拉杷醌; alpha-Lapachone | CFN98702 | 4707-33-9 | C15H14O3 = 242.3 | 5mg | QQ客服：2159513211 |
| 维生素 K1; Vitamin K1 | CFN90050 | 84-80-0 | C31H46O2 = 450.7 | 20mg | QQ客服：2056216494 |
| 2,6-二甲氧基-1,4-苯醌 ; 2,6-Dimethoxy-1,4-benzoquinone | CFN98883 | 530-55-2 | C8H8O4 = 168.2 | 20mg | QQ客服：215959384 |
| 大叶茜草素; Mollugin | CFN98930 | 55481-88-4 | C17H16O4 = 284.3 | 20mg | QQ客服：2056216494 |
| 4,9-二羟基-alpha-拉帕醌; 4,9-Dihydroxy-alpha-lapachone | CFN98947 | 56473-67-7 | C15H14O5 = 274.3 | 5mg | QQ客服：1413575084 |
| (1-羟基-4-氧代-2,5-环己二烯-1-基)乙酸乙酯; Ethyl(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate | CFN97022 | 60263-06-1 | C10H12O4 = 196.2 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)